The market for on-body drug delivery devices is poised to take off, with recent formulation technology advances and industry initiatives paving the way for next-generation innovations. Given current trends toward reduced dosing frequency and associated increases in payload volumes—combined with an enhanced focus on improving costs, patient convenience and quality of care—demand is growing for offerings that can support self-administration in more expansive, adaptable ways. Are on-body drug delivery devices ready to address the challenge? Read our February 2023 Pharmaceutical Manufacturing and Packing Sourcer (PMPS) magazine article* for timely answers and insights provided by Tony Bedford, director of front-end innovation for Phillips-Medisize.
For additional insights that can help you make the most of today’s rapidly evolving market environment, also take advantage of the resources listed below.
